Marché européen de la gestion des maladies chroniques – Tendances et prévisions du secteur jusqu’en 2028

Personnalisez votre rapport Personnalisez votre rapport Acheter maintenantAcheter maintenant Exemple de rapport gratuitExemple de rapport gratuit
Maison Healthcare Europe Chronic Disease Management Market
Demande de table des matières Demande de table des matières Parler à un analysteParler à un analyste Acheter maintenantAcheter maintenant Renseignez-vous avant d'acheterRenseignez-vous avant Exemple de rapport gratuitExemple de rapport gratuit

Marché européen de la gestion des maladies chroniques – Tendances et prévisions du secteur jusqu’en 2028

  • Healthcare
  • Publish Reports
  • Jun 2021
  • Europe
  • 350 Pages
  • Nombre de tableaux : 109
  • Nombre de figures : 45
Buy Now Acheter maintenant

Marché européen de la gestion des maladies chroniques, par type (solution et services), type de solution (solution sur site, solution basée sur le cloud, solution basée sur le Web), type de service (service éducatif, service de mise en œuvre, service de conseil et autres), indication de maladie (maladies cardiovasculaires (MCV), diabète, bronchopneumopathie chronique obstructive (BPCO), arthrite, asthme, cancer et autres), utilisateur final (prestataires de soins de santé, payeurs de soins de santé, autres), pays (Royaume-Uni, Allemagne, France, Espagne, Italie, Pays-Bas, Suisse, Russie, Belgique, Turquie, Irlande, reste de l'Europe) Tendances et prévisions de l'industrie jusqu'en 2028

Marché européen de la gestion des maladies chroniques

Analyse et perspectives du marché : marché européen de la gestion des maladies chroniques

Le marché de la gestion des maladies chroniques devrait connaître une croissance du marché au cours de la période de prévision de 2021 à 2028. Data Bridge Market Research analyse que le marché croît avec un TCAC de 13,7 % au cours de la période de prévision de 2021 à 2028 et devrait atteindre 591,09 millions USD d'ici 2028. La prévalence croissante des maladies chroniques devrait agir comme un moteur pour le marché de la gestion des maladies chroniques.

La gestion des maladies chroniques (GMC) consiste en des soins et un soutien continus destinés à aider les personnes touchées par une maladie chronique à obtenir les soins médicaux, les connaissances, les compétences et les ressources dont elles ont besoin pour mieux gérer leur quotidien. Elle est principalement assurée par divers logiciels et services. La gestion des maladies chroniques contribue à réduire les coûts des soins de santé et à améliorer la qualité de vie des personnes atteintes de maladies chroniques en prévenant ou en minimisant les effets de la maladie grâce à des soins intégrés.

L'augmentation de la population gériatrique devrait stimuler le marché de la gestion des maladies chroniques. Le manque d'accessibilité devrait restreindre le marché de la gestion des maladies chroniques. L'essor des nouvelles avancées technologiques devrait créer une opportunité pour le marché de la gestion des maladies chroniques. Le manque d'accessibilité devrait constituer un défi pour le marché de la gestion des maladies chroniques.

Le rapport sur le marché de la gestion des maladies chroniques fournit des détails sur la part de marché, les nouveaux développements et l'analyse du pipeline de produits, l'impact des acteurs du marché national et local, analyse les opportunités en termes de poches de revenus émergentes, les changements dans la réglementation du marché, les approbations de produits, les décisions stratégiques, les lancements de produits, les expansions géographiques et les innovations technologiques sur le marché. Pour comprendre l'analyse et le scénario du marché de la gestion des maladies chroniques, contactez Data Bridge Market Research pour un briefing d'analyste, notre équipe vous aidera à créer une solution d'impact sur les revenus pour atteindre votre objectif souhaité.

Marché européen de la gestion des maladies chroniques

Portée et taille du marché de la gestion des maladies chroniques

The chronic disease management market is segmented on the basis of the type, solution type, service type, Disease indication and end user. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of type, the chronic disease management market is segmented into solution and services. In 2021, solution segment is expected to dominate the chronic disease management market due to rising healthcare expenditure.  . 
  • On the basis of solution type, the chronic disease management market is segmented into on-premise solution, cloud-based solution and web-based. In 2021, on-premise solution segment is expected to dominate the chronic disease management market due to development in healthcare infrastructure. .
  • On the basis of service type, the chronic disease management market is segmented into education service, implementation service, consulting service and others. In 2021, implementation services segment is expected to dominate the chronic disease management market due to growing demand for advanced chronic disease management services. 
  • On the basis of Disease indication, the chronic disease management market is segmented into cardiovascular diseases (CVD), diabetes, chronic obstructive pulmonary disorders (COPD), arthritis, asthma, cancer and others. In 2021, cardiovascular diseases (CVD) segment is expected to dominate the chronic disease management market due to rising rate of early diagnosis of cardiovascular diseases (CVD). 
  • On the basis of end user, the chronic disease management market is segmented into healthcare providers, healthcare payers and others. In 2021, healthcare providers segment is expected to dominate the chronic disease management market due to advanced healthcare services provided by the healthcare providers.

Europe Chronic Disease Management Market Country Level Analysis

The disease management market is analyzed and market size information is provided by the country, type, solution type, service type, Disease indication and end user as referenced above.

The countries covered in the Europe chronic disease management market report are the Germany, France, Spain, Italy, Netherlands, Switzerland, Russia, Turkey, Austria, Ireland, and Rest of Europe.

Germany is expected to dominate the Europe chronic disease management market due to the presence of major market players and increased technological advancement in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Middle East and Africa brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Growing Strategic Activities by Major Market Players to enhance the Awareness for Chronic Disease Management is Boosting the Chronic Disease Management Market

The chronic disease management market also provides you with detailed market analysis for every country growth in chronic disease management market. Additionally, it provides the detail information regarding the chronic disease management market players’ strategy and their geographical presence. The data is available for historic period 2010 to 2019.

Competitive Landscape and Chronic Disease Management Market Share Analysis

The chronic disease management market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to Europe chronic disease management market.

The major companies dealing in the Europe chronic disease management market report are Koninklijke Philips N.V., WellSky, Health Catalyst, Cognizant, Pegasystems Inc., Epic Systems Corporation, Hinduja Global Solutions Ltd., NXGN Management, LLC, Casenet, LLC, ExlServings Holdings, Inc., ScienceSoft USA Corporation, Allscripts Healthcare, LLC., Infosys Limited,  IBM corporation, and IBM Corporation among other domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many contract and agreement are also initiated by the companies’ worldwide which are also accelerating the chronic disease management market.

For instance,

  • In April 2021, IBM Corporation launches advanced storage solutions designed to simplify data accessibility and availability across hybrid clouds. This new solution launch by parent organization IBM Corporation has enhanced the company’s overall revenue for market.

La collaboration, le lancement de produits, l'expansion commerciale, les récompenses et la reconnaissance, les coentreprises et d'autres stratégies des acteurs du marché renforcent l'empreinte de l'entreprise sur le marché de la gestion des maladies chroniques, ce qui offre également l'avantage de la croissance des bénéfices de l'organisation.

SKU-

Accédez en ligne au rapport sur le premier cloud mondial de veille économique

Sample Image Cliquez sur l'image pour l'agrandir
  • Tableau de bord d'analyse de données interactif
  • Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
  • Accès d'analyste de recherche pour la personnalisation et les requêtes
  • Analyse de la concurrence avec tableau de bord interactif
  • Dernières actualités, mises à jour et analyse des tendances
  • Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Demande de démonstration

Table des matières

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW of EUROPE chronic disease management market
    4. LIMITATIONs
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. MULTIVARIATE MODELLING
    7. type LIFELINE CURVE
    8. primary interviews with key opinion leaders
    9. DBMR MARKET POSITION GRID
    10. vendor share analysis
    11. MARKET END USER COVERAGE GRID
    12. secondary sourcEs
    13. assumptions
  3. EXECUTIVE SUMMARY
  4. PREMIUM INSIGHTS
  5. Europe chronic disease management market: regulations
    1. Regulation in the United States:
    2. Governing Regulations:
    3. CPT Codes:
    4. Practitioner Eligibility:
    5. Patient Eligibility:
    6. Requirements:
    7. Regulations in Europe:
    8. National Strategy and Lead Organizations for Healthcare services in Europe:
    9. Data Privacy Protection in Europe:
    10. Regulations in India:
    11. Relevant Acts for this framework:
    12. Data Privacy Protection in India:
  6. Market Overview
    1. Drivers
      1. INCREASING PREVALENCE OF chronic diseases
      2. Growing geriatric population
      3. Rising per capita income
      4. ADVANCEMENT IN HEALTHCARE INFRASTRUCTURE AND INITIATIVE ACTIVITIES BY GOVERNMENT ORGANIZATION
    2. Restraints
      1. High cost of Services
      2. Security concerns with cloud-based solutions
    3. OPPORTUNITIES
      1. Surge in novel technological advancements
      2. Rising healthcare expenditure
      3. increased reimbursement policies
      4. rising disease management programs
    4. CHALLENGE
      1. Lack of accessibility
  7. IMPACT OF COVID-19 ON THE Europe Chronic disease management Market
    1. IMPACT ON PRICE
    2. impact on demand
    3. STRATEGIC DECISIONS of Government and MANUFACTURERS
    4. Conclusion
  8. Europe chronic disease management market, By type
    1. overview
    2. solution
    3. services
  9. Europe chronic disease management market, By Solution Type
    1. overview
    2. On Premise Solution
    3. Web Based Solution
    4. Cloud Based Solution
  10. Europe chronic disease management market, By SERVICES Type
    1. overview
    2. Implementation Services
    3. Consulting Services
    4. Education Services
    5. OTHERS
  11. Europe chronic disease management market, By disease indication
    1. overview
    2. cardiovascular diseases (cvd)
    3. diabetes
    4. chronic obstructive pulmonary disorders (copd)
    5. asthma
    6. arthritis
    7. cancer
    8. otherS
  12. Europe chronic disease management market, By end user
    1. overview
    2. healthcare providers
      1. hospitals, physician groups, integrated delivery
      2. diagnostic & imaging centers
      3. ambulatory care centers
      4. home healthcare agencies, nursing homes & assisted living facilities
      5. others
    3. healthcare payers
      1. public payers
      2. private payers
    4. others
  13. Europe Chronic Disease Management Market by region
    1. EUROPE
      1. Germany
      2. U.K.
      3. France
      4. Italy
      5. Spain
      6. Netherlands
      7. Belgium
      8. Switzerland
      9. Russia
      10. Turkey
      11. Rest of Europe
  14. EUROPE CHRONIC DISEASE MANAGEMENT Market: COMPANY landscape
    1. company share analysis: Europe
  15. swot analysis
  16. Company profiles
    1. IBM corporation
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. SERVICE PORTFOLIO
      5. RECENT DEVELOPMENTS
    2. Koninklijke Philips N.V.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    3. COGNIZANT
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    4. allscripts healthcare, llc
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. SOLUTION PORTFOLIO
      5. RECENT DEVELOPMENTS
    5. ALTRUISTA HEALTH
      1. COMPANY SNAPSHOT
      2. SOLUTION PORTFOLIO
      3. RECENT DEVELOPMENTS
    6. casenet, llc
      1. COMPANY SNAPSHOT
      2. PRODUCT & SERVICE PORTFOLIO
      3. RECENT DEVELOPMENTS
    7. Cedar Gate Technologies
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    8. cliexa, inc.
      1. COMPANY SNAPSHOT
      2. SOLUTION PORTFOLIO
      3. RECENT DEVELOPMENTS
    9. Epic Systems Corporation
      1. COMPANY SNAPSHOT
      2. SERVICE PORTFOLIO
      3. RECENT DEVELOPMENT
    10. exlservice holdings, INC.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. SERVICE PORTFOLIO
      4. RECENT DEVELOPMENTS
    11. Health Catalyst
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    12. Hinduja Europe Solutions Ltd.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    13. infosys limited
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. SOLUTION PORTFOLIO
      4. RECENT DEVELOPMENTS
    14. medecision
      1. COMPANY SNAPSHOT
      2. SOLUTION PORTFOLIO
      3. RECENT DEVELOPMENT
    15. MINES & Associates, Inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    16. NXGN Management, LLC
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    17. Pegasystems Inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    18. Sciencesoft usa corporation
      1. COMPANY SNAPSHOT
      2. INDUSTRY PORTFOLIO
      3. RECENT DEVELOPMENTS
    19. tcs healthcare technologies
      1. COMPANY SNAPSHOT
      2. SERVICE PORTFOLIO
      3. RECENT DEVELOPMENTS
    20. vivify health, inc.
      1. COMPANY SNAPSHOT
      2. SOLUTION PORTFOLIO
      3. RECENT DEVELOPMENTS
    21. WellSky
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    22. ZEOMEGA
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
  17. questionnaire
  18. related reports

Liste des tableaux

TABLE 1 NUMBER OF PEOPLE WITH DIABETES AMONG 20–79 YEARS OLD (IN MILLION)

TABLE 2 NEW CANCER CASES FOR AGE 85+ IN THE U.S.

TABLE 3 PER CAPITA AMOUNTS: THE UNITED STATES (1960–2017)

TABLE 4 PRICES OF ESSENTIAL CHRONIC DISEASE MANAGEMENT SOLUTIONS

TABLE 5 Europe chronic disease management market, By type, 2019-2028 (USD million)

TABLE 6 Europe solution IN CHRONIC DISEASE MANAGEMENT MARKET, By region, 2019-2028 (USD million)

TABLE 7 Europe services IN CHRONIC DISEASE MANAGEMENT MARKET, By region, 2019-2028 (USD million)

TABLE 8 Europe chronic disease management market, By Solution type, 2019-2028 (USD million)

TABLE 9 Europe On Premise solution IN CHRONIC DISEASE MANAGEMENT MARKET, By region, 2019-2028 (USD million)

TABLE 10 Europe Web Based Solution IN CHRONIC DISEASE MANAGEMENT MARKET, By region, 2019-2028 (USD million)

TABLE 11 Europe Cloud Based Solution IN CHRONIC DISEASE MANAGEMENT MARKET, By region, 2019-2028 (USD million)

TABLE 12 Europe chronic disease management market, By Services type, 2019-2028 (USD million)

TABLE 13 Europe implementation services IN CHRONIC DISEASE MANAGEMENT MARKET, By region, 2019-2028 (USD million)

TABLE 14 Europe consulting services IN CHRONIC DISEASE MANAGEMENT MARKET, By region, 2019-2028 (USD million)

TABLE 15 Europe education services IN CHRONIC DISEASE MANAGEMENT MARKET, By region, 2019-2028 (USD million)

TABLE 16 Europe education services IN CHRONIC DISEASE MANAGEMENT MARKET, By region, 2019-2028 (USD million)

TABLE 17 Europe chronic disease management market, By disease indication, 2019-2028 (USD million)

TABLE 18 Europe cardiovascular diseases (cvd) IN CHRONIC DISEASE MANAGEMENT MARKET, By region, 2019-2028 (USD million)

TABLE 19 Europe diabetes IN CHRONIC DISEASE MANAGEMENT MARKET, By region 2019-2028 (USD million)

TABLE 20 Europe chronic obstructive pulmonary disorders (copd) IN CHRONIC DISEASE MANAGEMENT MARKET, By region, 2019-2028 (USD million)

TABLE 21 Europe asthma IN CHRONIC DISEASE MANAGEMENT MARKET, By region, 2019-2028 (USD million)

TABLE 22 Europe arthritis IN CHRONIC DISEASE MANAGEMENT MARKET, By region, 2019-2028 (USD million)

TABLE 23 Europe cancer IN CHRONIC DISEASE MANAGEMENT MARKET, By region, 2019-2028 (USD million)

TABLE 24 Europe others IN CHRONIC DISEASE MANAGEMENT MARKET, By region, 2019-2028 (USD million)

TABLE 25 Europe chronic disease management market, By end user, 2019-2028 (USD million)

TABLE 26 Europe healthcare roviders IN CHRONIC DISEASE MANAGEMENT MARKET, By region, 2019-2028 (USD million)

TABLE 27 Europe healthcare roviders in chronic disease management market, By end user, 2019-2028 (USD million)

TABLE 28 Europe healthcare payers IN CHRONIC DISEASE MANAGEMENT MARKET, By region, 2019-2028 (USD million)

TABLE 29 Europe healthcare payers in chronic disease management market, By end user, 2019-2028 (USD million)

TABLE 30 Europe others IN CHRONIC DISEASE MANAGEMENT MARKET, By region, 2019-2028 (USD million)

TABLE 31 EUROPE Chronic Disease Management Market, By COUNTRY, 2019-2028 (USD Million)

TABLE 32 Europe Chronic Disease Management Market, By Type, 2019-2028 (USD Million)

TABLE 33 Europe Solution in Chronic Disease Management Market, By SOLUTION Type, 2019-2028 (USD Million)

TABLE 34 Europe Services in Chronic Disease Management Market, By SERVICE Type, 2019-2028 (USD Million)

TABLE 35 Europe Chronic Disease Management Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 36 Europe Chronic Disease Management Market, By End User, 2019-2028 (USD Million)

TABLE 37 Europe Healthcare Providers in Chronic Disease Management Market, By End User, 2019-2028 (USD Million)

TABLE 38 Europe Healthcare Payers in Chronic Disease Management Market, By End User, 2019-2028 (USD Million)

TABLE 39 Germany Chronic Disease Management Market, By Type, 2019-2028 (USD Million)

TABLE 40 Germany Solution in Chronic Disease Management Market, By SOLUTION Type, 2019-2028 (USD Million)

TABLE 41 Germany Services in Chronic Disease Management Market, By SERVICE Type, 2019-2028 (USD Million)

TABLE 42 Germany Chronic Disease Management Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 43 Germany Chronic Disease Management Market, By End User, 2019-2028 (USD Million)

TABLE 44 Germany Healthcare Providers in Chronic Disease Management Market, By End User, 2019-2028 (USD Million)

TABLE 45 Germany Healthcare Payers in Chronic Disease Management Market, By End User, 2019-2028 (USD Million)

TABLE 46 U.K. Chronic Disease Management Market, By Type, 2019-2028 (USD Million)

TABLE 47 U.K. Solution in Chronic Disease Management Market, By SOLUTION Type, 2019-2028 (USD Million)

TABLE 48 U.K. Services in Chronic Disease Management Market, By SERVICE Type, 2019-2028 (USD Million)

TABLE 49 U.K. Chronic Disease Management Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 50 U.K. Chronic Disease Management Market, By End User, 2019-2028 (USD Million)

TABLE 51 U.K. Healthcare Providers in Chronic Disease Management Market, By End User, 2019-2028 (USD Million)

TABLE 52 U.K. Healthcare Payers in Chronic Disease Management Market, By End User, 2019-2028 (USD Million)

TABLE 53 France Chronic Disease Management Market, By Type, 2019-2028 (USD Million)

TABLE 54 France Solution in Chronic Disease Management Market, By SOLUTION Type, 2019-2028 (USD Million)

TABLE 55 France Services in Chronic Disease Management Market, By SERVICE Type, 2019-2028 (USD Million)

TABLE 56 France Chronic Disease Management Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 57 France Chronic Disease Management Market, By End User, 2019-2028 (USD Million)

TABLE 58 France Healthcare Providers in Chronic Disease Management Market, By End User, 2019-2028 (USD Million)

TABLE 59 France Healthcare Payers in Chronic Disease Management Market, By End User, 2019-2028 (USD Million)

TABLE 60 Italy Chronic Disease Management Market, By Type, 2019-2028 (USD Million)

TABLE 61 Italy Solution in Chronic Disease Management Market, By SOLUTION Type, 2019-2028 (USD Million)

TABLE 62 Italy Services in Chronic Disease Management Market, By SERVICE Type, 2019-2028 (USD Million)

TABLE 63 Italy Chronic Disease Management Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 64 Italy Chronic Disease Management Market, By End User, 2019-2028 (USD Million)

TABLE 65 Italy Healthcare Providers in Chronic Disease Management Market, By End User, 2019-2028 (USD Million)

TABLE 66 Italy Healthcare Payers in Chronic Disease Management Market, By End User, 2019-2028 (USD Million)

TABLE 67 Spain Chronic Disease Management Market, By Type, 2019-2028 (USD Million)

TABLE 68 Spain Solution in Chronic Disease Management Market, By SOLUTION Type, 2019-2028 (USD Million)

TABLE 69 Spain Services in Chronic Disease Management Market, By SERVICE Type, 2019-2028 (USD Million)

TABLE 70 Spain Chronic Disease Management Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 71 Spain Chronic Disease Management Market, By End User, 2019-2028 (USD Million)

TABLE 72 Spain Healthcare Providers in Chronic Disease Management Market, By End User, 2019-2028 (USD Million)

TABLE 73 Spain Healthcare Payers in Chronic Disease Management Market, By End User, 2019-2028 (USD Million)

TABLE 74 Netherlands Chronic Disease Management Market, By Type, 2019-2028 (USD Million)

TABLE 75 Netherlands Solution in Chronic Disease Management Market, By SOLUTION Type, 2019-2028 (USD Million)

TABLE 76 Netherlands Services in Chronic Disease Management Market, By SERVICE Type, 2019-2028 (USD Million)

TABLE 77 Netherlands Chronic Disease Management Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 78 Netherlands Chronic Disease Management Market, By End User, 2019-2028 (USD Million)

TABLE 79 Netherlands Healthcare Providers in Chronic Disease Management Market, By End User, 2019-2028 (USD Million)

TABLE 80 Netherlands Healthcare Payers in Chronic Disease Management Market, By End User, 2019-2028 (USD Million)

TABLE 81 Belgium Chronic Disease Management Market, By Type, 2019-2028 (USD Million)

TABLE 82 Belgium Solution in Chronic Disease Management Market, By SOLUTION Type, 2019-2028 (USD Million)

TABLE 83 Belgium Services in Chronic Disease Management Market, By SERVICE Type, 2019-2028 (USD Million)

TABLE 84 Belgium Chronic Disease Management Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 85 Belgium Chronic Disease Management Market, By End User, 2019-2028 (USD Million)

TABLE 86 Belgium Healthcare Providers in Chronic Disease Management Market, By End User, 2019-2028 (USD Million)

TABLE 87 Belgium Healthcare Payers in Chronic Disease Management Market, By End User, 2019-2028 (USD Million)

TABLE 88 Switzerland Chronic Disease Management Market, By Type, 2019-2028 (USD Million)

TABLE 89 Switzerland Solution in Chronic Disease Management Market, By SOLUTION Type, 2019-2028 (USD Million)

TABLE 90 Switzerland Services in Chronic Disease Management Market, By SERVICE Type, 2019-2028 (USD Million)

TABLE 91 Switzerland Chronic Disease Management Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 92 Switzerland Chronic Disease Management Market, By End User, 2019-2028 (USD Million)

TABLE 93 Switzerland Healthcare Providers in Chronic Disease Management Market, By End User, 2019-2028 (USD Million)

TABLE 94 Switzerland Healthcare Payers in Chronic Disease Management Market, By End User, 2019-2028 (USD Million)

TABLE 95 Russia Chronic Disease Management Market, By Type, 2019-2028 (USD Million)

TABLE 96 Russia Solution in Chronic Disease Management Market, By SOLUTION Type, 2019-2028 (USD Million)

TABLE 97 Russia Services in Chronic Disease Management Market, By SERVICE Type, 2019-2028 (USD Million)

TABLE 98 Russia Chronic Disease Management Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 99 Russia Chronic Disease Management Market, By End User, 2019-2028 (USD Million)

TABLE 100 Russia Healthcare Providers in Chronic Disease Management Market, By End User, 2019-2028 (USD Million)

TABLE 101 Russia Healthcare Payers in Chronic Disease Management Market, By End User, 2019-2028 (USD Million)

TABLE 102 Turkey Chronic Disease Management Market, By Type, 2019-2028 (USD Million)

TABLE 103 Turkey Solution in Chronic Disease Management Market, By SOLUTION Type, 2019-2028 (USD Million)

TABLE 104 Turkey Services in Chronic Disease Management Market, By SERVICE Type, 2019-2028 (USD Million)

TABLE 105 Turkey Chronic Disease Management Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 106 Turkey Chronic Disease Management Market, By End User, 2019-2028 (USD Million)

TABLE 107 Turkey Healthcare Providers in Chronic Disease Management Market, By End User, 2019-2028 (USD Million)

TABLE 108 Turkey Healthcare Payers in Chronic Disease Management Market, By End User, 2019-2028 (USD Million)

TABLE 109 Rest of Europe Chronic Disease Management Market, By Type, 2019-2028 (USD Million)

Liste des figures

FIGURE 1 Europe CHRONIC DISEASE MANAGEMENT MARKET: SEGMENTATION

FIGURE 2 EUROPE CHRONIC DISEASE MANAGEMENT MARKET: DATA TRIANGULATION

FIGURE 3 Europe Chronic disease management market: DROC ANALYSIS

FIGURE 4 Europe Chronic disease management market: Europe VS REGIONAL MARKET ANALYSIS

FIGURE 5 Europe Chronic disease management market: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE Chronic disease management market: MULTIVARIATE MODELLING

FIGURE 7 EUROPE Chronic disease management market: INTERVIEW DEMOGRAPHICS

FIGURE 8 EUROPE CHRONIC DISEASE MANAGEMENT MARKET: DBMR MARKET POSITION GRID

FIGURE 9 EUROPE CHRONIC DISEASE MANAGEMENT MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 EUROPE chronic disease management market: MARKET END USER COVERAGE GRID

FIGURE 11 Europe Chronic disease management market: SEGMENTATION

FIGURE 12 growing geriatric population is expected to DRIVe THE Europe Chronic disease management market IN THE FORECAST PERIOD OF 2021 to 2028

FIGURE 13 SOLUTION SEGMENT is expected to account for the largest share of the Europe CHRONIC DISEASE MANAGEMENT MARKET in 2021 & 2028

FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGE OF Europe chronic disease management market

FIGURE 15 prevalence of chronic diseases

FIGURE 16 AGING POPULATION In the world (in millions)

FIGURE 17 North AMERICA AGING POPULATION (In millionS)

FIGURE 18 Europe AGING POPULATION (In millionS)

FIGURE 19 Asia-pacific AGING POPULATION (In millionS)

FIGURE 20 Europe chronic disease management market: By type, 2020

FIGURE 21 Europe chronic disease management market: By type, 2019-2028 (USD million)

FIGURE 22 Europe chronic disease management market: By type, CAGR (2021-2028)

FIGURE 23 Europe chronic disease management market: By type, LIFELINE CURVE

FIGURE 24 Europe chronic disease management market: By Solution type, 2020

FIGURE 25 Europe chronic disease management market: By Solution type, 2019-2028 (USD million)

FIGURE 26 Europe chronic disease management market: By Solution type, CAGR (2021-2028)

FIGURE 27 Europe chronic disease management market: By Solution type, LIFELINE CURVE

FIGURE 28 Europe chronic disease management market: By Services type, 2020

FIGURE 29 Europe chronic disease management market: By Services type, 2019-2028 (USD million)

FIGURE 30 Europe chronic disease management market: By Services type, CAGR (2021-2028)

FIGURE 31 Europe chronic disease management market: By Services type, LIFELINE CURVE

FIGURE 32 Europe chronic disease management market: By disease indication, 2020

FIGURE 33 Europe chronic disease management market: By disease indication, 2019-2028 (USD million)

FIGURE 34 Europe chronic disease management market: By disease indication, CAGR (2021-2028)

FIGURE 35 Europe chronic disease management market: By disease indication, LIFELINE CURVE

FIGURE 36 Europe chronic disease management market: By end user, 2020

FIGURE 37 Europe chronic disease management market: By end user, 2019-2028 (USD million)

FIGURE 38 Europe chronic disease management market: By end user, CAGR (2021-2028)

FIGURE 39 Europe chronic disease management market: By end user, LIFELINE CURVE

FIGURE 40 EUROPE Chronic Disease Management MARKET: SNAPSHOT (2020)

FIGURE 41 EUROPE Chronic Disease Management MARKET: BY COUNTRY (2020)

FIGURE 42 EUROPE Chronic Disease Management MARKET: BY COUNTRY (2021 & 2028)

FIGURE 43 EUROPE Chronic Disease Management MARKET: BY COUNTRY (2020 & 2028)

FIGURE 44 EUROPE Chronic Disease Management MARKET: BY TYPE (2021-2028)

FIGURE 45 Europe Chronic Disease Management market: company share 2020 (%)

Voir les informations détaillées Right Arrow

Méthodologie de recherche

La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.

La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.

Personnalisation disponible

Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.

Parcourir les pages associées

Banner